Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

635
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
635
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

248
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
248

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to [DIAB-D-25-04607: "1-hour plasma glucose in referred populations: functional marker or overstated risk?"].

Diabetes research and clinical practice·2025
Same author

Development and Validation of a Novel Plasma Metabolomic Signature for the Detection of Renal Cell Carcinoma.

European urology·2025
Same author

Insulin resistance and β-cell dysfunction in individuals with normal glucose tolerance but elevated 1-h post-load plasma glucose.

Frontiers in endocrinology·2025
Same author

The roles and responsibilities of general practice nurses in China: a qualitative study.

BMC primary care·2024
Same author

[Clinical characteristics and treatment in adults and children with histiocytic necroti-zing lymphadenitis].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2024
Same author

[Efficient biosynthesis of γ-aminobutyric acid by rationally engineering the catalytic pH range of a glutamate decarboxylase from <i>Lactobacillus plantarum</i>].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2023

Related Experiment Video

Updated: Aug 26, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Latent feature representation learning for Alzheimer's disease classification.

Aimei Dong1, Guodong Zhang1, Jian Liu1

  • 1Faculty of Computer Science and Technology,Qilu University of Technology(Shandong Academy of Sciences),Jinan, 250353, China.

Computers in Biology and Medicine
|October 10, 2022
PubMed
Summary

Early Alzheimer's Disease (AD) detection is crucial. This study introduces a novel latent feature fusion method using multi-modality imaging for more effective automatic AD diagnosis.

Keywords:
Alzheimer’s diseaseFeature fusionLatent feature representationLocal geometry constraintsMulti-modality data

More Related Videos

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.0K

Related Experiment Videos

Last Updated: Aug 26, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.0K

Area of Science:

  • Neuroimaging
  • Machine Learning
  • Medical Diagnostics

Background:

  • Early detection and treatment of Alzheimer's Disease (AD) are critical for patient outcomes.
  • Multi-modality imaging data has shown promise in advancing automatic AD diagnosis.

Purpose of the Study:

  • To propose a novel method for Alzheimer's Disease classification using latent feature fusion.
  • To effectively leverage information from multi-modality imaging data for improved diagnostic accuracy.

Main Methods:

  • A latent feature fusion approach is proposed.
  • A specific projection matrix is learned for each imaging modality.
  • Binary label matrices and local geometry constraints are introduced to project features into a low-dimensional space.
  • Latent feature representations from different modalities are fused for classification.

Main Results:

  • The proposed method demonstrates effectiveness in classifying Alzheimer's Disease.
  • Experimental validation was conducted using the Alzheimer's Disease Neuroimaging Initiative database.

Conclusions:

  • Latent feature fusion is a promising technique for Alzheimer's Disease diagnosis using multi-modality imaging.
  • The developed method offers an effective approach for automatic AD classification.